| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |